Advancing personalized healthcare in infectious disease with multi-omics profiling
Date: Jun 10, 2025
Dr. Neogi illustrates how integrating proteomics, transcriptomics and metabolomics data from multinational cohorts guided the development of a 21-plex Olink® Flex protein biomarker panel that could be used for monitoring patients with HIV.
Application focusAdvancing Precision Medicine in Inflammatory Diseases with Affinity-Based Proteomics
Psoriatic arthritis (PsA) is a chronic inflammatory disease affecting joints, entheses, and skin, and is linked to higher risks of cardiovascular disease and MASLD. These associations reflect complex inflammation-metabolism interactions, but treatment effects remain unclear.
10 Apr 2025
- Product insights
A Complete Solution for Identifying Protein Signatures: From Sample to Actionable Results
Explore how the Olink® Signature Q100 benchtop system and NPX Signature software are part of a complete solution for generating meaningful protein signatures, from study design to data interpretation.
03 Apr 2025
Maternal inflammation during pregnancy and risk of immune-mediated diseases in birth cohorts
Jonathan Thorsen, MD Ph.D., Senior Researcher at COPSAC, presents a webinar on the HEDIMED project, which analyzed perinatal blood samples from four northern European birth cohorts to identify immune markers for childhood diseases, using the Olink Target96 Inflammation platform.
04 Apr 2024